Feasibility of SOLAR Group Program Among MHPSS Workers After the Earthquake
Launched by KOÇ UNIVERSITY · Jan 22, 2024
Trial Information
Current as of May 19, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program called the SOLAR Group Program, designed to help mental health and psychosocial support (MHPSS) workers who are helping survivors of the earthquakes that occurred in Türkiye on February 6, 2023. The main goal is to see if this program can reduce feelings of psychological distress, secondary trauma, anxiety, and depression among these workers. Participants will fill out a few questionnaires before and after the program to measure their mental health and well-being.
To be eligible for this trial, you need to be at least 18 years old, work as an MHPSS worker providing support to earthquake survivors, and have some level of emotional distress. However, if you have thoughts of suicide, you cannot participate. If you choose to join, you'll take part in a five-week program and complete some evaluations to help understand the program's impact on your mental health. Your feedback will be important in understanding how well the SOLAR Group Program works.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • at least 18 years of age
- • actively working as an MHPSS worker who provides psychosocial support to the survivors of the February 6 earthquake
- • having subclinical symptoms of distress (score\>20 on The Kessler Psychological Distress Scale (K10)
- • no suicidal risk.
- Exclusion Criteria:
- • not approving the informed consent
- • having a suicidal thought.
About Koç University
Koç University, a leading multidisciplinary research institution located in Istanbul, Turkey, is dedicated to advancing healthcare through innovative clinical research. With a commitment to excellence in education and research, the university fosters collaboration among experts in various fields, aiming to translate scientific discoveries into practical applications that improve patient outcomes. Koç University’s clinical trial initiatives are characterized by rigorous methodologies, ethical standards, and a focus on addressing pressing health challenges, positioning it as a pivotal player in the global research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Trial Officials
Ceren Acartürk
Study Director
Koç University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported